secwatch.observer — SEC 8-K summary
======================================

Issuer:     Agentix Corp. (AGTX)
CIK:        0001603345
Form:       8-K
Filed at:   2021-07-16T23:59:59+00:00
Accession:  0001477932-21-004665
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agentix Corp. completes merger with Applied Biopharma LLC; interests converted to common stock
--------------------------------------------------------------------------------

- Merger completed July 14, 2021: AB Merger LLC merged into Applied Biopharma, with Applied Biopharma surviving.
- Each Applied Biopharma LLC interest was converted into one share of Agentix common stock ($0.001 par).
- Articles of Merger filed with Nevada Secretary of State on July 14, 2021.
- Merger Agreement dated July 13, 2021, previously filed as Exhibit 2.1 to a July 14, 2021 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1603345/000147793221004665/0001477932-21-004665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1603345/000147793221004665/agtx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-21-004665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer